# New Technique of Reverse Bone Grafting With Core Decompression and Enriching With Regenerative Medicine Techniques for Grade 2 and Grade 3 Avascular Necrosis of Both Hips

**Authors:** Saksham Goyal, Sandeep Shrivastav, Ratnakar Ambade, Aditya Pundkar, Ashutosh Lohiya

PMC · DOI: 10.7759/cureus.51425 · Cureus · 2023-12-31

## TL;DR

A new method combining bone grafting, core decompression, and regenerative treatments like PRP and BMAC helped reduce pain and improve hip function in a young man with early avascular necrosis.

## Contribution

The novel approach integrates regenerative medicine techniques with traditional orthopedic procedures for treating early-stage hip avascular necrosis.

## Key findings

- The patient experienced significant pain reduction after the combined treatment.
- Functional improvements were observed in both hips post-surgery.
- The combination of regenerative therapies and orthopedic interventions shows promise for early AVN treatment.

## Abstract

Early avascular necrosis (AVN) of the hip poses a significant clinical challenge, requiring prompt recognition and intervention to mitigate long-term complications. A case report describing a 30-year-old man with bilateral hip AVN is presented here. In addition, to reverse bone grafting and core decompression of both hips, the patient had platelet-rich plasma (PRP) infiltration in the right hip and bone marrow aspirate concentrate (BMAC) infiltration in the left hip. This method attempted to stop the disease's development and promote hip regeneration in both. Significant pain reduction and postoperative functional gains in both hips are seen in this instance. These results highlight the potential of combined orthopedic and regenerative therapies in young individuals with hip AVN and highlight the necessity of early intervention for maintaining long-term hip function.

## Linked entities

- **Diseases:** avascular necrosis (MONDO:0018373)

## Full-text entities

- **Diseases:** hip pain (MESH:D010146), arthritis (MESH:D001168), infection (MESH:D007239), cysts (MESH:D003560), collapse (MESH:D001261), degenerative hip (MESH:C564185), sickle cell disease (MESH:D000755), osteoarthritis (MESH:D010003), clotting disorders (MESH:D020141), thrombophilia (MESH:D019851), osteonecrotic lesion (MESH:D009059), femoral head osteonecrosis (MESH:D000070603), trauma (MESH:D014947), coagulation disorders (MESH:D001778), osteoporotic (MESH:D058866), systemic illness (MESH:D012140), hip (MESH:D025981), vascular insufficiency (MESH:D065666), subchondral fracture (MESH:D001845), COVID-19 (MESH:D000086382), Necrosis (MESH:D009336), AVN of the hip (MESH:D010020), SLE (MESH:D008180)
- **Chemicals:** vitamin D3 (MESH:D002762), bisphosphonate (MESH:D004164), calcium (MESH:D002118), alendronate (MESH:D019386), alcohol (MESH:D000438), steroid (MESH:D013256), BMAC (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10828746/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10828746/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC10828746/full.md

---
Source: https://tomesphere.com/paper/PMC10828746